![Robert Lisicki](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Lisicki
No open positions remaining
Net worth: - $ as of 30/05/2026
Profile
Robert Lisicki worked as Vice President & General Manager at Amgen, Inc. from 2005 to 2014.
From 2014 to 2018, served as Chief Customer Officer, SVP-Sales & Marketing at Daiichi Sankyo, Inc. Between 2018 and 2022, held the position of Chief Commercial Officer & Executive VP at Arena Pharmaceuticals, Inc. Worked at Regeneron Pharmaceuticals, Inc. as General Manager & Vice President-Cardio Metabolic.
From 2022 to 2023, was Chief Executive Officer & Director at InCarda Therapeutics, Inc. Served as Chief Executive Officer & Director at Zura Bio Ltd. from 2024 to 2025.
Held director roles at Adiso Therapeutics, Inc. (2023-2024) and Independent Director at Cadrenal Therapeutics, Inc. (2023-2025).
Education includes undergraduate studies at the State University of New York at Albany.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 19/04/2026 | 0 ( -.--% ) | - $ | 30/05/2026 |
Former positions of Robert Lisicki
| Companies | Position | End |
|---|---|---|
| ZURA BIO LIMITED | Chief Executive Officer | 09/10/2025 |
| CADRENAL THERAPEUTICS, INC. | Director/Board Member | 14/07/2025 |
Adiso Therapeutics, Inc.
 Adiso Therapeutics, Inc. BiotechnologyHealth Technology Provides biotechnology research services | Director/Board Member | 31/07/2024 |
InCarda Therapeutics, Inc.
 InCarda Therapeutics, Inc. BiotechnologyHealth Technology Develops transforming cardiovascular disease treatment through pulmonary delivery of established drugs | Chief Executive Officer | 28/02/2023 |
| ARENA PHARMACEUTICALS | Corporate Officer/Principal | 28/02/2022 |
Training of Robert Lisicki
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
73
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Regeneron Pharmaceuticals, Inc.
 Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
State University of New York at Albany
 State University of New York at Albany Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Daiichi Sankyo, Inc.
 Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. BiotechnologyHealth Technology Develops transforming cardiovascular disease treatment through pulmonary delivery of established drugs | Health Technology |
Adiso Therapeutics, Inc.
Adiso Therapeutics, Inc. BiotechnologyHealth Technology Provides biotechnology research services | Health Technology |
Zura Bio Ltd.
 Zura Bio Ltd. BiotechnologyHealth Technology Operates as a multi-asset clinical-stage biotechnology company that focuses on develops novel medicines for immune and inflammatory disorders | Health Technology |
Cadrenal Therapeutics, Inc.
 Cadrenal Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel therapy with orphan drug indication | Health Technology |
- Stock Market
- Insiders
- Robert Lisicki
